GRN and metabolic syndrome: Elevated PGRN expression in visceral adipose tissue and circulating PGRN concentrations are associated with visceral obesity, type 2 diabetes, and dyslipidemia (Youn et al., 2009; Qu et al., 2013; Shafaei et al., 2016).